STKH Q2 2024 Earnings Call Summary | Stock Taper
Logo
STKH

STKH — Steakholder Foods Ltd.

NASDAQ


Q2 2024 Earnings Call Summary

September 5, 2024

Summary of Steakholder Foods Limited Q2 2024 Earnings Call

1. Key Financial Results and Metrics

  • Net Loss: Decreased by 54% to $4.4 million ($1.10 per share) from $9.5 million ($5.00 per share) in H1 2023.
  • R&D Expenses: Reduced by 54% to $1.6 million from $3.6 million year-over-year, indicating a shift from R&D to commercialization.
  • Marketing Expenses: Decreased by 56% to $700,000 from $1.6 million.
  • General and Administrative Expenses: Fell by 9% to $2 million from $2.2 million.
  • Cash Position: Ended H1 2024 with $5.4 million in cash, up from $4.2 million at the end of 2023.

2. Strategic Updates and Business Highlights

  • Transitioned to a B2B model focusing on two revenue streams: selling 3D printers and meat/fish premix blends.
  • Secured four significant commercialization agreements:
    • Wyler Farm: Multimillion-dollar agreement for alternative protein production.
    • ITRI: Partnership to develop food products tailored for Taiwanese cuisine.
    • Sherry Herring: Collaboration to launch vegan fish salads.
    • Premazon: Partnership for plant-based white fish kebabs.
  • Received a $1 million grant from the Singapore-Israel Industrial R&D Foundation, with the first payment of $220,000 received.

3. Forward Guidance and Outlook

  • Anticipates first commercial revenue generation by late 2024 or early 2025.
  • Projects accelerated revenue growth in 2025, supported by ongoing negotiations for a global commercial agreement expected to be announced in early 2025.
  • Focus on securing additional commercial deals and expanding market reach.

4. Bad News, Challenges, or Points of Concern

  • While the company has made significant strides, it remains in the early stages of commercialization, which introduces execution risks.
  • The need for continued innovation and adaptation to market demands remains critical, especially in a competitive landscape for alternative proteins.
  • The company has not yet generated commercial revenue, which raises concerns about cash flow sustainability until products are launched.

5. Notable Q&A Insights

  • No questions were raised during the Q&A session, indicating either a lack of engagement from investors or confidence in the management's presentation.
  • CEO Arik Kaufman emphasized the challenging environment for growth startups and expressed optimism about upcoming product launches and potential customer acquisition.

This summary encapsulates the key points from Steakholder Foods' Q2 2024 earnings call, highlighting both the progress made and the challenges ahead as the company transitions to a commercial phase.